With the novel coronavirus spreading throughout the world, there are calls for a treatment to be made practical as soon…...
Please subscribe to read the full story.
Gilead Sciences
Gilead Sciences Works on New Platform for Business Growth
Gilead Sciences Inc. is looking to strengthen its development of new drugs in Japan beyond those for the hepatitis C…...
Please subscribe to read the full story.
Daiichi Sankyo Sees Pillar of Growth in Next-Gen Biopharmaceuticals
Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and…...
Please subscribe to read the full story.
